• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Elements of religiosity and spirituality help predict clinical response to treatment in adults with mild-to-moderate depression

byAshley Jackson
December 22, 2023
in Psychiatry, Wellness
Reading Time: 2 mins read
Children’s hospital visits for suicide ideation and attempts are increasing
Share on FacebookShare on Twitter

1. In this randomized controlled trial, depressed patients who received Meditation-Based Lifestyle Modification (MBLM) had a greater increase in spirituality than those who received treatment as usual.

2. Furthermore, baseline interest in spirituality and engagement in mind-body practice were two predictive factors of improved depression and perceived stress in response to treatment.

Evidence Rating Level: 1 (Excellent)

Religiosity and spirituality (R/S) are associated with several positive mental health effects, including improvements in dementia, depression, and substance abuse. However, other studies have found negative effects of R/S on mental health through religious struggle. Meditation-Based Lifestyle Modification (MBLM) is a newer intervention that combines a focus on the mind and body with spirituality. Prior research has found that MBLM is effective in improving moderate depression. However, there is still a lack of understanding of how R/S plays into the effects of MBLM on depression. This study aimed to assess the role that R/S has in the treatment effects of MBLM on mild-to-moderate depression.

This randomized controlled trial included 81 participants at a psychiatry, psychosomatics, and psychotherapy clinic in Germany. Participants were included if they were adult psychiatric outpatients who were diagnosed with mild or moderate depression. Participants were randomized into one of three groups. The first group received 8 weeks of MBLM treatment, the second received treatment as usual (TAU), which consisted of tailored multimodal therapy, and the third received no further treatment, only drug continuation therapy. Following this, participants were randomized to either TAU or TAU and MBLM for 16 weeks. Depression severity was assessed using the Beck Depression Inventory (BDI)-II. Spirituality was assessed using a 5-point scaled question, the Aspects of Spirituality (ASP) questionnaire, and the Spiritual and Religious Attitudes in Dealing with Illness (SpREUK) questionnaire. The primary outcome was the impact of the treatment on spirituality, as assessed by the various spirituality questionnaires.

The results demonstrated that patients who received MBLM treatment had an increase in spirituality compared to the other treatment groups at 8 weeks. This effect was evidenced by higher scores on the various spirituality questionnaires, including metrics related to religious orientation, spiritual practices, and more. At 6 months, participants who received MBLM treatment demonstrated significantly higher scores on the various spirituality questionnaires than those who received TAU. There were two variables that were identified at 6 months that could predict the change in depression and perceived stress in these groups, and these were baseline interest in spirituality and baseline engagement in mind-body practice. However, the study was limited by the use of patient-rated questionnaires, which may have introduced bias. Nonetheless, the present study demonstrated that R/S can be a predictive factor of clinical outcomes in the treatment of depression.

RELATED REPORTS

Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Click to read the study in Journal of Integrative and Complementary Medicine

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: clinical responsedepressionmeditationreligiosityspiritualitystresswellness
Previous Post

Statin use may reduce risk of venous thromboembolism in women taking hormone therapy

Next Post

#VisualAbstract: No increase in mortality with paclitaxel-coated devices among patients with femoropopliteal disease

RelatedReports

Chronic Disease

Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma

September 28, 2026
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Next Post
#VisualAbstract: No increase in mortality with paclitaxel-coated devices among patients with femoropopliteal disease

#VisualAbstract: No increase in mortality with paclitaxel-coated devices among patients with femoropopliteal disease

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Low eosinophil counts associated with increased acute bacterial infection risk in older adults

Prevalence of hypertension among adolescents varies by race and BMI

Elevated systemic inflammation markers associated with increased prevalence of hypertension

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Robotic cholecystectomy benefits high-risk and higher-BMI patients but costs more
  • Antibiotics after appendectomy were not associated with reduced postoperative infections
  • Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.